HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to the development of therapies for rare diseases: drug pricing; Medicare and Medicaid; R&D tax expensing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSANNA AGUIRRE HASTINGS New | — |
Pharmacy PHA
Issues related to the development of therapies for rare diseases: drug pricing; Medicare and Medicaid; R&D tax expensing. H.R. 5547, Maintaining Investments in New Innovation (MINI) Act H.R.7174 Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act H.R. 6664, Innovation in Pediatric Drugs Act H.R. 7384, Creating Hope Reauthorization Act H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act H.R.7024 - Tax Relief for American Families and Workers Act of 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSANNA AGUIRRE HASTINGS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.